The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus

J Hum Hypertens. 2010 Jan;24(1):74-6. doi: 10.1038/jhh.2009.84.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldosterone / blood
  • Amine Oxidase (Copper-Containing) / physiology
  • Atrial Natriuretic Factor / blood
  • Cross-Over Studies
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Endothelins / blood
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • PPAR gamma / agonists*
  • Pioglitazone
  • Renin / blood
  • Thiazolidinediones / pharmacology*

Substances

  • Endothelins
  • Hypoglycemic Agents
  • PPAR gamma
  • Thiazolidinediones
  • Aldosterone
  • Atrial Natriuretic Factor
  • Amine Oxidase (Copper-Containing)
  • Renin
  • Pioglitazone